References
- Avert. (2019). HIV and AIDS in China. Retrieved July 10, 2020, from https://www.avert.org/professionals/hiv-around-world/asia-pacific/china
- Centers for Disease Control and Prevention. (2014). Preexposure prophylaxis for the prevention of HIV infection in the United States – Clinical providers supplement. 2014. Retrieved July 10, 2020, from https://www.cdc.gov/hiv/pdf/prepprovidersupplement2014.pdf
- Chapman, A., Hadfield, M., & Chapman, C. (2015). Qualitative research in healthcare: An introduction to grounded theory using thematic analysis. Journal of the Royal College of Physicians of Edinburgh, 45(3), 201–205. https://doi.org/https://doi.org/10.4997/jrcpe.2015.305
- Chemnasiri, T., Varangrat, A., Amico, K. R., Chitwarakorn, A., Dye, B. J., Grant, R. M., & Holtz, T. H. (2020). Facilitators and barriers affecting PrEP adherence among Thai men who have sex with men (MSM) in the HPTN 067/ADAPT study. AIDS Care, 32(2), 249–254. https://doi.org/https://doi.org/10.1080/09540121.2019.1623374
- Defechereux, P. A., Mehrotra, M., Liu, A. Y., McMahan, V. M., Glidden, D. V., Mayer, K. H., & iPrEx Study Team. (2016). Depression and oral FTC/TDF pre-exposure prophylaxis (PrEP) among men and transgender women who have sex with men (MSM/TGW). AIDS and Behavior, 20(7), 1478–1488. https://doi.org/https://doi.org/10.1007/s10461-015-1082-2
- Edelman, E. J., Moore, B. A., Calabrese, S. K., Berkenblit, G., Cunningham, C. O., Ogbuagu, O., Patel, V. V., Phillips, K. A., Tetrault, J. M., Shah, M., & Blackstock, O. (2020). Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): Results from a survey of primary care providers. Preventive Medicine Reports, 17, 101012. https://doi.org/https://doi.org/10.1016/j.pmedr.2019.101012
- Gilead Press Release. (2020). China National Medical Products Administration Approves Truvada® for HIV Pre-Exposure Prophylaxis (PrEP). https://www.gileadchina.com/en/news/press-releases/2020/8/china-national-medical-products-administration-approves-truvada
- He, H., Lv, F., Zhang, N. N., Wu, Z., Liao, Q., Chang, Z., Li, Y., Xu, H., OuYang, L., Huan, X., & Yang, J. (2017). Look into the HIV epidemic of gay community with a socio-cultural perspective: A qualitative study in China, 2015–2016. Plos One, 12(1). https://doi.org/https://doi.org/10.1371/journal.pone.0170457
- Holt, M., Murphy, D. A., Callander, D., Ellard, J., Rosengarten, M., Kippax, S. C., & Wit, J. B. (2012). Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sexually Transmitted Infections, 88(4), 258–263. https://doi.org/https://doi.org/10.1136/sextrans-2011-050312
- Marcus, J. L., Volk, J. E., Pinder, J., Liu, A. Y., Bacon, O., Hare, C. B., & Cohen, S. E. (2016). Successful implementation of HIV preexposure prophylaxis: Lessons learned from three Clinical settings. Current HIV/AIDS Reports, 13(2), 116–124. https://doi.org/https://doi.org/10.1007/s11904-016-0308-x
- Mehrotra, M. L., Glidden, D. V., McMahan, V., Amico, K. R., Hosek, S., Defechereux, P., Mayer, K. H., Veloso, V. G., Bekker, L.-G., Avelino-Silva, V. I., Schechter, M., Grant, R. M.(2016). The effect of depressive symptoms on adherence to daily oral PrEP in men who have sex with men and transgender women: A marginal structural model analysis of the iPrEx OLE study. AIDS and Behavior, 20(7), 1527–1534. https://doi.org/https://doi.org/10.1007/s10461-016-1415-9
- Mi, G., Ma, B., Kleinman, N., Li, Z., Fuller, S., Bulterys, M., Hladik, W., & Wu, Z. (2016). Hidden and mobile: A Web-based study of migration patterns of men who have sex with men in China. Clinical Infectious Diseases, 62(11), 1443–1447. https://doi.org/https://doi.org/10.1093/cid/ciw167
- Pinto, R. M., Berringer, K. R., Melendez, R., & Mmeje, O. (2018). Improving PrEP implementation through multilevel interventions: A synthesis of the literature. AIDS and Behavior, 22(11), 3681–3691. https://doi.org/https://doi.org/10.1007/s10461-018-2184-4
- Raifman, J. R., Flynn, C., & German, D. (2017). Healthcare provider contact and pre-exposure prophylaxis in Baltimore men who have sex with men. American Journal of Preventive Medicine, 52(1), 55–63. https://doi.org/https://doi.org/10.1016/j.amepre.2016.07.031
- Time Weekly. (2020). The first HIV pre-exposure prophylaxis drug on the market: Gilead plans to bring in four new HIV antiretroviral therapy drugs into China in three years. December 28, 2020. Retrieved from https://www.time-weekly.com/post/277145.
- Veronese, V., Clouse, E., Wirtz, A. L., Thu, K. H., Naing, S., Baral, S. D., Stoové, M., & Beyrer, C. (2019). “We are not gays … don’t tell me those things”: engaging ‘hidden’ men who have sex with men and transgender women in HIV prevention in Myanmar. BMC Public Health, 19(1). https://doi.org/https://doi.org/10.1186/s12889-018-6351-3
- Werner, R. N., Gaskins, M., Ahrens, J., Jessen, H., Kutscha, F., Mosdzen, R., Osswald, W., Sander, D., Schellberg, S., Schwabe, K., Wünsche, T., Dressler, C., Sammons, M., & Nast, A. (2018). Knowledge and use of HIV pre-exposure prophylaxis among men who have sex with men in Berlin – A multicentre, cross-sectional survey. Plos One, 13(9), e0204067. https://doi.org/https://doi.org/10.1371/journal.pone.0204067
- World Health Organization. (2012). Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: Recommendations for use in the context of demonstration projects, July 2012. Retrieved July 10, 2020, from http://www.who.int/iris/handle/10665/75188
- Zimmermann, H. M., Eekman, S. W., Achterbergh, R. C., Van Der Loeff, M. F. S., Prins, M., Vries, H. J., Hoornenborg, E., & Davidovich, U. (2019). Motives for choosing, switching and stopping daily or event-driven pre-exposure prophylaxis – A qualitative analysis. Journal of the International AIDS Society, 22(10). https://doi.org/https://doi.org/10.1002/jia2.25389